Clinical Trials Logo

Clinical Trial Summary

The purpose of the study is to determine the safety and effectiveness of dilation and evacuation for surgical abortion as compared to medical abortion


Clinical Trial Description

All patients with a gestational age between 13-20 weeks are fully counseled on the risks and benefits and given the option of medical or surgical abortion. Those who choose medical abortion receive mifepristone 200 mg on day 1 and are appointed to return to SPHMMC 24-48 hours later for admission and misoprostol administration. Those who chose surgical abortion are given mifepristone 200 mg with or without laminaria and appointed to return the next day for surgical abortion. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04602052
Study type Interventional
Source St. Paul's Hospital Millennium Medical College, Ethiopia
Contact
Status Completed
Phase N/A
Start date November 1, 2018
Completion date October 31, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT05326854 - NAVIGATION ASSISTED CARE PROGRAM AND TERMINATION OF PREGNANCY N/A
Completed NCT00994734 - Uptake and Acceptability of Home-use of Mifepristone for Medical Abortion N/A
Not yet recruiting NCT04303949 - Multi-Media E-Book for Second‐Trimester Termination Due to Fetal Anomaly N/A
Completed NCT04910958 - Impact of COVID-19 Pandemic on Early Spontaneous Abortions and Early Termination of Pregnancy
Completed NCT03393455 - Obstetric & Pediatric Evolution Following Parental Refusal for Early Termination of Pregnancy Despite Fetal Risk
Completed NCT03877900 - A Feasibility Study of Virtopsy With Tissue Sampling in Besancon University Hospital
Completed NCT02597699 - Use of Ultiva ® Associated With Xylocaine ® in the Procedures of Feticide Phase 3
Enrolling by invitation NCT03494842 - TENS for Suction Evacuation for Termination of 1st Trimester Pregnancies N/A
Completed NCT01811056 - Exploring a Patient-centered Approach to Mifepristone Administration in Medical Abortion N/A
Completed NCT03802149 - Ulipristal Acetate for Cervical Preparation Early Phase 1